How Drug Shortages Spur Drug Compounding
Published On:
December 17, 2024
We’ve all seen the news stories about drug compounders filling the gap caused by a shortage of the GLP-1 drugs tirzepatide, Lilly’s Zepbound, and semaglutide, Novo Nordisk’s Wegovy, approved for the treatment of obesity. So, what rules govern how a compounding pharmacy is authorized to legally create a version of a patented drug when the drug is declared to be in short supply?
Read Blog